Latest News

Epizyme Announces Positive Pre-NDA Meeting for Tazemetostat for Follicular Lymphoma, Pipeline Updates and Third Quarter 2019 Results


CAMBRIDGE, Mass.–(BUSINESS WIRE)–Epizyme Announces Positive Pre-NDA Meeting for Tazemetostat for Follicular Lymphoma, Pipeline Updates and Third Quarter 2019 Results

Source link




Related posts

Efficient vaccination strategies for epidemic control using network information

Newsemia

Deep brain stimulation has state-dependent effects on motor connectivity in Parkinson's disease

Newsemia

Le programme clinique d’Ipsen pour le palovarotène dans la fibrodysplasie ossifiante progressive atteint le critère de futilité lors de l’analyse intérimaire prévue au protocole

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy